Clinical Trial Update: The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

View source ↗

Summary

This clinical trial update reports the completion of the humanitarian device exemption post-approval study (H070005) of the AMPLATZER Post-Infarct Muscular VSD …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-infarction Ventricular Septal Defect

Drugs mentioned

• AMPLATZER Post-Infarct Muscular VSD Occluder

Snippet

Sponsor: Abbott Medical Devices | Conditions: Post-Infarction Ventricular Septal Defect | Status: COMPLETED | Results posted: 2024-10-10